12 October 2023
Pharmaceutics | Selected Papers in 2021 in the Section “Drug Delivery and Controlled Release”


1. “Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery”
by Rebekah Omarkhail Elliott and Mei He
Pharmaceutics 2021, 13(1), 122; https://doi.org/10.3390/pharmaceutics13010122
Available online: https://www.mdpi.com/1999-4923/13/1/122

2. “Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives”
by Hyeong Min Kim and Se Joon Woo
Pharmaceutics 2021, 13(1), 108; https://doi.org/10.3390/pharmaceutics13010108
Available online: https://www.mdpi.com/1999-4923/13/1/108

3. “Peptide-Based Strategies for Targeted Tumor Treatment and Imaging”
by Abiodun Ayo and Pirjo Laakkonen
Pharmaceutics 2021, 13(4), 481; https://doi.org/10.3390/pharmaceutics13040481
Available online: https://www.mdpi.com/1999-4923/13/4/481

4. “Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation”
by Felipe M. González-Fernández, Annalisa Bianchera, Paolo Gasco, Sara Nicoli and Silvia Pescina
Pharmaceutics 2021, 13(4), 447; https://doi.org/10.3390/pharmaceutics13040447
Available online: https://www.mdpi.com/1999-4923/13/4/447

5. “Formulation Considerations for the Management of Dry Eye Disease”
by Priyanka Agarwal, Jennifer P. Craig and Ilva D. Rupenthal
Pharmaceutics 2021, 13(2), 207; https://doi.org/10.3390/pharmaceutics13020207
Available online: https://www.mdpi.com/1999-4923/13/2/207

6. “Mesoporous Silica Particles as Drug Delivery Systems—The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes”
by Katarzyna Trzeciak, Agata Chotera-Ouda, Irena I. Bak-Sypien and Marek J. Potrzebowski
Pharmaceutics 2021, 13(7), 950; https://doi.org/10.3390/pharmaceutics13070950
Available online: https://www.mdpi.com/1999-4923/13/7/950

7. “Microemulsion-Based Media in Nose-to-Brain Drug Delivery”
by Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri and Bozena Michniak-Kohn
Pharmaceutics 2021, 13(2), 201; https://doi.org/10.3390/pharmaceutics13020201
Available online: https://www.mdpi.com/1999-4923/13/2/201

8. “Nanomaterials for Protein Delivery in Anticancer Applications”
by Anne Yau, Jinhyung Lee and Yupeng Chen
Pharmaceutics 2021, 13(2), 155; https://doi.org/10.3390/pharmaceutics13020155
Available online: https://www.mdpi.com/1999-4923/13/2/155

9. “Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics”
by Kai K. Ewert, Pablo Scodeller, Lorena Simón-Gracia, Victoria M. Steffes, Emily A. Wonder, Tambet Teesalu and Cyrus R. Safinya
Pharmaceutics 2021, 13(9), 1365; https://doi.org/10.3390/pharmaceutics13091365
Available online: https://www.mdpi.com/1999-4923/13/9/1365

10. “Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities”
by Rabin Neupane, Sai H. S. Boddu, Mariam Sami Abou-Dahech, Rinda Devi Bachu, David Terrero, R. Jayachandra Babu and Amit K. Tiwari
Pharmaceutics 2021, 13(7), 960; https://doi.org/10.3390/pharmaceutics13070960
Available online: https://www.mdpi.com/1999-4923/13/7/960

11. “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery”
by Rafaela Santos de Oliveira, Stephani Silva Fantaus, Antonio José Guillot, Ana Melero and Ruy Carlos Ruver Beck
Pharmaceutics 2021, 13(11), 1946; https://doi.org/10.3390/pharmaceutics13111946
Available online: https://www.mdpi.com/1999-4923/13/11/1946

12. “Graphene Oxide and Graphene Quantum Dots as Delivery Systems of Cationic Porphyrins: Photo-Antiproliferative Activity Evaluation towards T24 Human Bladder Cancer Cells”
by Luca Menilli, Ana R. Monteiro, Silvia Lazzarotto, Filipe M. P. Morais, Ana T. P. C. Gomes, Nuno M. M. Moura, Sara Fateixa, Maria A. F. Faustino, Maria G. P. M. S. Neves, Tito Trindade et al.
Pharmaceutics 2021, 13(9), 1512; https://doi.org/10.3390/pharmaceutics13091512
Available online: https://www.mdpi.com/1999-4923/13/9/1512

13. “Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability”
by Daniel Andrés Real, Karen Bolaños, Josefina Priotti, Nicolás Yutronic, Marcelo J. Kogan, Rodrigo Sierpe and Orlando Donoso-González
Pharmaceutics 2021, 13(12), 2131; https://doi.org/10.3390/pharmaceutics13122131
Available online: https://www.mdpi.com/1999-4923/13/12/2131

14. “PEGylated Mesoporous Silica Nanoparticles (MCM-41): a Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells”
by Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J. Cabot, Nazrul Islam and Emad L. Izake
Pharmaceutics 2021, 13(10), 1605; https://doi.org/10.3390/pharmaceutics13101605
Available online: https://www.mdpi.com/1999-4923/13/10/1605

You can check all publications in the Section “Drug Delivery and Controlled Release” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1031.

Back to TopTop